Does LAMIVUDINE Cause Ventricular septal defect? 86 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 86 reports of Ventricular septal defect have been filed in association with LAMIVUDINE (Lamivudine and Zidovudine). This represents 0.5% of all adverse event reports for LAMIVUDINE.
86
Reports of Ventricular septal defect with LAMIVUDINE
0.5%
of all LAMIVUDINE reports
3
Deaths
2
Hospitalizations
How Dangerous Is Ventricular septal defect From LAMIVUDINE?
Of the 86 reports, 3 (3.5%) resulted in death, 2 (2.3%) required hospitalization.
Is Ventricular septal defect Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LAMIVUDINE. However, 86 reports have been filed with the FAERS database.
What Other Side Effects Does LAMIVUDINE Cause?
Foetal exposure during pregnancy (1,905)
Virologic failure (1,894)
Drug resistance (1,889)
Pathogen resistance (1,733)
Viral mutation identified (1,631)
Treatment failure (933)
Exposure during pregnancy (846)
Drug interaction (744)
Drug ineffective (726)
Immune reconstitution inflammatory syndrome (625)
What Other Drugs Cause Ventricular septal defect?
ONDANSETRON (301)
LAMOTRIGINE (238)
PAROXETINE (225)
SERTRALINE (193)
LEVETIRACETAM (172)
FLUOXETINE (171)
CITALOPRAM HYDROBROMIDE (158)
VENLAFAXINE (152)
ASPIRIN (146)
RAMIPRIL (145)
Which LAMIVUDINE Alternatives Have Lower Ventricular septal defect Risk?
LAMIVUDINE vs LAMIVUDINE\NEVIRAPINE\ZIDOVUDINE
LAMIVUDINE vs LAMIVUDINE\TENOFOVIR
LAMIVUDINE vs LAMIVUDINE\TENOFOVIR DISOPROXIL
LAMIVUDINE vs LAMIVUDINE\ZIDOVUDINE
LAMIVUDINE vs LAMOTRIGINE